Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2019

Nov 08, 2019

SELL
$19.51 - $24.28 $1.95 Million - $2.43 Million
-100,000 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$21.47 - $37.33 $178,201 - $309,839
-8,300 Reduced 7.66%
100,000 $2.25 Million
Q1 2019

May 15, 2019

BUY
$28.4 - $36.49 $3.08 Million - $3.95 Million
108,300 New
108,300 $3.95 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.67B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.